Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Thrombolytic therapy in patients with ischemic stroke in the vertebrobasilar system

https://doi.org/10.14412/2074-2711-2012-399

Full Text:

Abstract

The paper shows the efficiency and safety of increasing the therapeutic window for systemic thrombolysis in verified ischemic stroke in the vertebrobasilar system (VBS), as well as the possibility of effective reperfusion in patients with stenotic occlusive lesions of the basilar artery and clinical signs of severe truncal stroke. Thrombolytic therapy (TLT) over 4.5 hours and in a neurological deficit of >25 scores according to the National Institute of Health (NIHSS) Scale should be performed only within the framework of clinical trials. TLT for stroke in the VBS may substantially alter the approach to rendering care in this pathology and contribute to an increase in the number of patients with a good functional outcome.

References

1. <div><p>Caplan L. Posterior circulation ischemia: then, now, and tomorrow. The Thomas Willis Lecture-2000. Stroke 2000;31(8):2011-23.</p><p>Gulli G., Khan S., Markus H.S. Vertebrobasilar stenosis predicts high early recurrent stroke risk in posterior circulation stroke and TIA. Stroke 2009;40(8):2732-7.</p><p>Caplan L.R., Chung C.-S., Wityk R.J. et al. New England medical center posterior circulation stroke registry: I. Methods, data base, distribution of brain lesions, stroke mechanisms, and outcomes. J Clin Neurol 2005;1(1):14-30.</p><p>Glass T.A., Hennessey P.M., Pazdera L. et al. Outcome at 30 days in the New England Medical Center Posterior Circulation Registry. Arch Neurol 2002;59(3):369—76.</p><p>Hornig C.R., Büttner T., Hoffmann O. et al. Short-Term Prognosis of Vertebrobasilar Ischemic Stroke. Cerebrovasc Dis 1992;2:273-81.</p><p>Caplan L.R., Wityk R.J., Glass T.A. et al. New England Medical Center Posterior Circulation registry. Ann Neurol 2004;56(3):389-98.</p><p>Gomez C.R., Malik M.M., Wingkun E. et al. "Locked-in" syndrome. Stroke 1987;18(1):275.</p><p>Скворцова В.И., Голухов Г.Н., Волнынский Ю.Д. и др. Высокая эффективность селективного внутриартериального тромболизиса при лечении ишемического инсульта у больных с окклюзией артерий крупного калибра. Журн неврол и психиатр 2006;12:32-40.</p><p>A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Stroke 1997;28(8):1530—40.</p><p>Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28(11):2119-25.</p><p>Clark W.M., Wissman S., Albers G.W. et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282(21):2019-26.</p><p>Grotta J.C., Welch K.M.A., Fagan S.C. et al. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke 2001;32(3):661—8.</p><p>Hacke W., Kaste M., Bluhmki E. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359(13):1317—29.</p><p>Hacke W., Kaste M., Fieschi C. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274(13):1017-25.</p><p>Hacke W., Kaste M., Fieschi C. et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352(9136):1245—51.</p><p>Jaillard A., Cornu C., Durieux A. et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke 1999;30(7):1326-32.</p><p>Larrue V., von Kummer R.R., Müller A. et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32(2):438—41.</p><p>Motto C., Ciccone A., Aritzu E. et al. Hemorrhage after an acute ischemic stroke.MAST-I Collaborative Group. Stroke 1999;30(4):761-4.</p><p>Adams H.P. Jr., del Zoppo G., Alberts M.J. et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38(5):1655—711.</p><p>Cao F., Hata R., Zhu P. et al. Delayed neuronal cell death in brainstem after transient brainstem ischemia in gerbils. BMC Neurosci 2010;11:115.</p><p>Hata R., Matsumoto M., Hatakeyama T. et al. Differential vulnerability in the hindbrain neurons and local cerebral blood flow during bilateral vertebral occlusion in gerbils. Neuroscience 1993;56(2):423—39.</p><p>Brandt T. Diagnosis and thrombolytic therapy of acute basilar artery occlusion: a review. Clin Exp Hypertens 2002;24(7—8):611 —22.</p><p>Becker K.J., Monsein L.H., Ulatowski J. et al. Intraarterial thrombolysis in vertebrobasilar occlusion. AJNR Am J Neuroradiol 1996;17(2):255—62.</p><p>Brandt T., von Kummer R., Muller-Kuppers M. et al. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996;27(5):875—81.</p><p>Eckert B., Kucinski T., Pfeiffer G. et al. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 2002;14(1):42—50.</p><p>Hacke W., Zeumer H., Ferbert A. et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19(10):1216—22.</p><p>Lindsberg P.J., Mattle H.P. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006;37(3):922-8.</p><p>Pfefferkorn T., Holtmannspötter M., Schmidt C. et al. Drip, ship, and retrieve: cooperative recanalization therapy in acute basilar artery occlusion. Stroke 41(4):722—6.</p><p>Smith W.S. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007;38(Suppl 2):701-3.</p><p>Arnold M., Nedeltchev K., Schroth G. et al. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004;75(6):857-62.</p><p>Cross D.T.3rd, Moran C.J., Akins P.T. et al. Relationship between clot location and outcome after basilar artery thrombolysis. AJNR Am J Neuroradiol 1997;18(7):1221-8.</p><p>Brott T., Adams H.P. Jr., Olinger C.P. et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20(7):864-70.</p><p>Bonita R., Beaglehole R. Recovery of motor function after stroke. Stroke 1988;19(12):1497—500.</p><p>Mahoney F.I., Barthel D.W. Functional Evaluation: The Barthel Index. Md State Med J 1965;14:61-5.</p><p>Adams H.P. Jr., Bendixen B.H., Kappelle L.J. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24(1):35—41.</p><p>Вишнякова А.Ю., Анисимов К.В., Лелюк С.Э. и др. Эхографические признаки выраженных стеноокклюзирующих поражений основной артерии у пациентов с вертебрально-базилярным ишемическим инсультом. Ультразвук и функцион диагн 2012;3:65-75.</p><p>Лелюк В.Г., Лелюк С.Э. Ультразвуковая ангиология. 3-е изд. М.: Реал Тайм, 2007;416 с.</p><p>Тромболитическая терапия при ишемическом инсульте. Методические рекомендации под ред. В.И. Скворцовой. М., 2010;58 с.</p><p>Bluhmki E., Chamorro A., Davalos A. et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol 2009;8(12):1095—102.</p><p>Cronin C.A. Intravenous tissue plasminogen activator for stroke: a review of the ECASS III results in relation to prior clinical trials. J Emerg Med 38(1):99—105.</p><p>Davis S., Donnan G. The ECASS III results and the tPA paradox. Int J Stroke 2009;4(1):17-8.</p><p>Sandercock P., Wardlaw J.M., Lindley R.I. et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012;379(9834):2352—63.</p><p>Hill M.D., Hachinski V. Stroke treatment: time is brain. Lancet 1998;352(Suppl 3):SIII10-4.</p><p>Caplan L.R. Vertebrobasilar embolism. Clin Exp Neurol 1991;28:1-22.</p><p>Caplan L.R., Amarenco P., Rosengart A. et al. Embolism from vertebral artery origin occlusive disease. Neurology 1992;42(8):1505—12.</p><p>Levy E.I., Firlik A.D., Wisniewski S. et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intraarterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 1999;45(3):539—45;545—8.</p><p>Haugsted H. Occlusion of the basilar artery; diagnosis by vertebral angiography during life. Neurology 1956;6(11):823—8.</p><p>Schulte-Altedorneburg G., Hamann G.F., Mull M. et al. Outcome of acute vertebrobasilar occlusions treated with intra-arterial fibrinolysis in 180 patients. AJNR Am J Neuroradiol 2006;27(10):2042-7.</p></div><br />


For citation:


Anisimov K.V., Vishnyakova A.Y., Ramazanov G.R., Shamalov N.A., Lelyuk V.G., Skvortsova V.I. Thrombolytic therapy in patients with ischemic stroke in the vertebrobasilar system. Neurology, Neuropsychiatry, Psychosomatics. 2012;4(3):29-34. (In Russ.) https://doi.org/10.14412/2074-2711-2012-399

Views: 610


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)